PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0958
Bid: 0.093
Ask: 0.0958
Change: -0.0016 (-1.67%)
Spread: 0.0028 (3.011%)
Open: 0.0958
High: 0.0958
Low: 0.0958
Prev. Close: 0.096
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3D Printing with Graphene Trials

31 Mar 2016 07:00

RNS Number : 6154T
Versarien PLC
31 March 2016
 

 

31 March 2016

Versarien plc("Versarien" or the "Company")

 

3D Printing with Graphene Trials

 

Versarien plc (AIM: VRS), the advanced engineering materials group is pleased to announce that is working with with 3D printing specialists E3D Online Ltd in initial trials for incorporating graphene into its 3D printing process.

 

The aim of the trial is to test whether the exceptional properties of the graphene developed by 2D-Tech can be incorporated into 3D printed parts.

 

Sanjay Mortimer, Director of Research and Development at E3D Online Ltd commented: "E3D is constantly seeking to push boundaries in what is possible to achieve with 3D printing. Working with Versarien to incorporate graphene into 3D printed parts is extremely exciting and we look forward to creating enhanced materials with advanced properties that would not be possible without this collaboration."

Neill Ricketts, CEO of Versarien plc commented: "We are always looking for new and innovative applications for our graphene technology and we look forward to collaborating with E3D Online Ltd in progressing this potential use for graphene in 3D printed products. This is one of a number of graphene applications we are investigating and is an example of graphene moving from the lab to the real world."

 

For further information please contact:

 

Versarien plc

www.versarien.com

Neill Ricketts - Chief Executive Officer

+44 (0) 1594 888 622

Chris Leigh - Chief Financial Officer

 

 

 

WH Ireland (Nominated Adviser and Broker)

www.wh-ireland.co.uk

John Wakefield / Ed Allsopp

+44 (0) 117 945 3470

 

 

IFC Advisory (Financial PR and IR)

www.investor-focus.co.uk

Tim Metcalfe / Graham Herring / Heather Armstrong

+44 (0) 20 3053 8671

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAQBLFXQXFEBBE
Date   Source Headline
1st Dec 20224:41 pmRNSSecond Price Monitoring Extn
1st Dec 20224:35 pmRNSPrice Monitoring Extension
2nd Nov 20224:35 pmRNSPrice Monitoring Extension
30th Sep 202212:48 pmRNSResult of AGM
28th Sep 20224:41 pmRNSSecond Price Monitoring Extn
28th Sep 20224:36 pmRNSPrice Monitoring Extension
26th Sep 20227:00 amRNSBiaBrazil to utilise Graphene-Wear Technology
24th Aug 20227:00 amRNSNotice of AGM
30th Jun 20227:00 amRNSVerified Graphene Producer Re-certification
27th Jun 20227:00 amRNSLaunch of New Superparamagnetic Material
12th May 20227:00 amRNSInterim Results
10th May 20227:00 amRNSUmbro to Utilise Versarien’s Graphene-Wear Tech
3rd May 20227:00 amRNSNotice of Results and Investor Presentation
25th Apr 20223:25 pmRNSHolding(s) in Company
9th Mar 20227:00 amRNSLaunch of Lunar 3D printed lifestyle pods
24th Feb 20227:00 amRNSChange of Auditors and Accounting Reference Date
22nd Feb 20227:00 amRNSFlux Footwear to launch graphene enhanced shoe
20th Jan 20227:00 amRNSInvestor Event
4th Jan 20227:00 amRNSConfirmation of Board Change
24th Dec 20217:00 amRNSHolding(s) in Company
10th Dec 20217:00 amRNSInvestor Presentation
6th Dec 20217:00 amRNSInterim Results
2nd Dec 20217:00 amRNSNotice of Results and Investor Presentation
17th Nov 20212:27 pmRNSHolding(s) in Company
16th Nov 202112:31 pmRNSSuperdry partners with Versarien
11th Nov 20217:00 amRNSInvestor Presentation
1st Nov 20217:00 amRNSConsortium wins Department for Transport backing
29th Oct 20211:41 pmRNSResponse to Media Speculation
29th Oct 20217:00 amRNSInvestor Presentation
13th Oct 20217:00 amRNSAppointment of Non-executive Chairman
23rd Sep 20212:08 pmRNSResult of AGM
2nd Sep 202111:01 amRNSChange of Registered Address
27th Aug 20211:54 pmRNSNotice of AGM and Posting of Annual Report
11th Aug 20219:53 amRNSHolding(s) in Company
5th Aug 20217:00 amRNSPreliminary Results
30th Apr 20217:00 amRNSTotal Voting Rights
9th Apr 20217:00 amRNS£1.93m strategic investment by Graphene Lab
26th Feb 202110:16 amRNSInnovate UK Loan
9th Feb 20217:00 amRNSGraphene Enhanced Mask Update
22nd Jan 202111:05 amRNSDirector/PDMR Shareholding
21st Jan 20217:00 amRNSInterim Results
7th Jan 20217:00 amRNSAppointment of Chief Technology Officer
31st Dec 20207:00 amRNSTotal Voting Rights
30th Dec 20207:00 amRNSHolding(s) in Company
23rd Dec 202012:31 pmRNSHolding(s) in Company
22nd Dec 20207:00 amRNSAcquisition, Subscription & Sharing Agreement
24th Nov 20207:00 amRNS£1.95 million Development Agreement
23rd Nov 20204:39 pmRNSInterim Results Reporting Extension
18th Nov 20207:00 amRNSSARS-CoV-2 Inhibition by Graphene / Metal Oxides
21st Oct 202012:00 pmRNSResult of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.